BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 821837)

  • 1. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
    Leschek E; Pearlman SA; Boudreaux I; Meek R
    Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The present state of prevention of rhesus immunisation (author's transl)].
    Chavinié J; Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):569-75. PubMed ID: 81222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhesus immunoprevention by means of immunoglobulin anti-D].
    Maas DH; Schneider
    Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rhesus-prophylaxis during interventions in early pregnancy].
    Beck A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):613-8. PubMed ID: 6420996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 14. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)].
    Blanchard A; Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-D prevention. Review and outlook for 1976].
    Schneider J
    Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.